In vitro fertilization-embryo transfer in patients with unexplained recurrent pregnancy loss
Open Access
- 20 September 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 134 (20), 2421-2429
- https://doi.org/10.1097/cm9.0000000000001657
Abstract
Background: Empiric therapy for patients with unexplained recurrent pregnancy loss (URPL) is not precise. Some patients will ask for assisted reproductive technology due to secondary infertility or advanced maternal age. The clinical outcomes of URPL patients who have undergone in vitro fertilization-embryo transfer (IVF-ET) require elucidation. The IVF outcome and influencing factors of URPL patients need further study. Methods: A retrospective cohort study was designed, and 312 infertile patients with URPL who had been treated during January 2012 to December 2015 in the Reproduction Center of Peking University Third Hospital were included. By comparing clinical outcomes between these patients and those with tubal factor infertility (TFI), the factors affecting the clinical outcomes of URPL patients were analyzed. Results: The clinical pregnancy rate (35.18% vs. 34.52% in fresh ET cycles, P = 0.877; 34.48% vs. 40.27% in frozen-thawed ET cycles, P = 0.283) and live birth rate (LBR) in fresh ET cycles (27.67% vs. 26.59%, P = 0.785) were not significantly different between URPL group and TFI group. URPL group had lower LBR in frozen-thawed ET cycles than that of TFI group (23.56% vs. 33.56%, P = 0.047), but the cumulative LBRs (34.69% vs. 38.26%, P = 0.368) were not significantly different between the two groups. The increased endometrial thickness (EMT) on the human chorionic gonadotropin day (odds ratio [OR]: 0.848, 95% confidence interval [CI]: 0.748–0.962, P = 0.010) and the increased number of eggs retrieved (OR: 0.928, 95% CI: 0.887–0.970, P = 0.001) were protective factors for clinical pregnancy in stimulated cycles. The increased number of eggs retrieved (OR: 0.875, 95% CI: 0.846–0.906, P < 0.001), the increased two-pronucleus rate (OR: 0.151, 95% CI: 0.052–0.437, P < 0.001), and increased EMT (OR: 0.876, 95% CI: 0.770–0.997, P = 0.045) in ET day were protective factors for the cumulative live birth outcome. Conclusion: After matching ages, no significant differences in clinical outcomes were found between the patients with URPL and the patients with TFI. A thicker endometrium and more retrieved oocytes increase the probability of pregnancy in fresh transfer cycles, but a better normal fertilization potential will increase the possibility of a live birth.Keywords
This publication has 29 references indexed in Scilit:
- The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screeningFertility and Sterility, 2014
- Alteration in the Expression of Proteins in Unexplained Recurrent Pregnancy Loss Compared with in the Normal PlacentaThe Journal of Reproduction and Development, 2014
- Preimplantation genetic screening: a systematic review and meta-analysis of RCTsHuman Reproduction Update, 2011
- Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrificationFertility and Sterility, 2010
- Comparison ofin vitrofertilisation success in patients with polycystic ovary syndrome and tubal factorGynecological Endocrinology, 2010
- Aspirin plus Heparin or Aspirin Alone in Women with Recurrent MiscarriageThe New England Journal of Medicine, 2010
- Gene expression profiles of single human mature oocytes in relation to ageHuman Reproduction, 2010
- Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trialThe Lancet, 1999
- Semen parameters and sperm morphology in men in unexplained recurrent spontaneous abortion, before and during a 3 year follow-up periodHuman Reproduction, 1996
- Low molecular weight heparin use in unexplained recurrent miscarriage: safety and efficancyPakistan Journal of Medical Sciences, 1969